Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs Hirudin in Haemodialysis
NCT06112262Phase 1Not yet recruiting
- Start
- Dec 2023
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1 trial of recombinant hirudin in thrombosis. Primary endpoints: Number of bleeding events and Efficacy of dialysis. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
recombinant hirudin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT06112262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06112262.